Sun Pharmaceutical Industries Ltd (SUN.NS)

SUN.NS

About

Sun Pharmaceutical Industries Limited is an international specialty pharma company. The Company manufactures and markets pharmaceutical formulations as branded generics, as well as generics in India, the United states and several other markets across the world. The Company’s business is divided into four segments: Indian Branded... (more)

Buy/Sell

» Analyst Consensus

Overall

Beta:	0.50
Market Cap (Mil.):	Rs1,000,528.00
Shares Outstanding (Mil.):	1,035.58
Dividend:	4.25
Yield (%):	0.44

Financials

	SUN.NS	Industry	Sector
P/E (TTM):	35.43	35.66	35.83
EPS (TTM):	27.27	--	--
ROI:	--	19.36	18.72
ROE:	--	20.07	19.54

Latest News about SUN.NS

Indian shares gain for 4th day; Reliance, Sun Pharma lead

MUMBAI, April 2 - Indian shares inched higher for the fourth session on Tuesday with select blue-chips including Reliance Industries gaining on optimism about delivering good numbers while Sun Pharmaceuticals rose after a report of a price hike by a unit. Reliance Industries gained 2.14 percent while Sun Pharmaceutical Industries ended 5 percent higher. Reliance Communications Ltd gained 16.9 percent after signing a 12-billion-rupee pact with Reliance Jio Infocomm, a unit of R

02 Apr 2013

» More SUN.NS News

Earnings vs. Estimates

Analyst Research Reports

Report Title	Price
Thomson Reuters Stock Report - SUN PHARMACEUTICALS INDUSTRIES LTD (SUNPHARMA-IN) Provider: Thomson Reuters Stock Report	$25.00 Buy
Sun Pharmaceutical Industries closes at 4.1% above VWP Provider: News Bites Pty Limited	$5.00 Buy
Sun Pharmaceutical Industries rises 1.1% on firm volume Provider: News Bites Pty Limited	$5.00 Buy
Wright Investors Service Comprehensive Report for Sun Pharmaceuticals Industries Ltd Provider: Wright Reports	$472.00 Buy
Sun Pharmaceutical Industries lifts 2.1% on average volume Provider: News Bites Pty Limited	$5.00 Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Related Topics:

Edition:

U.S.
- Arabic
- Argentina
- Brazil
- Canada
- China
- France
- Germany
- India
- Italy
- Japan
- Latin America
- Mexico
- Russia
- Spain
- United Kingdom

Back to top

Reuters.com

Legal

Support & Contact

Connect with Reuters

About

Our Flagship financial information platform incorporating Reuters Insider

An ultra-low latency infrastructure for electronic trading and data distribution

A connected approach to governance, risk and compliance

Our next generation legal research platform

Our global tax workstation

Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.

NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.